209 related articles for article (PubMed ID: 22166693)
1. Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection.
Aziz S; Rajper J; Noor-ul-Ain W; Mehnaz A; Masroor M; Chang MH
J Coll Physicians Surg Pak; 2011 Dec; 21(12):735-40. PubMed ID: 22166693
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience.
Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV
Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre.
Das K; Ali H; Mahmood T; Munir SM; Ahmed T; Farooq MU
J Ayub Med Coll Abbottabad; 2008; 20(2):39-42. PubMed ID: 19385455
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome in patients of hepatitis B with hepatitis D: experience of 4 years at a tertiary care centre in Pakistan.
Zuberi BF; Quraishy MS; Afsar S; Akhtar N; Kumar A; Dodani SK
J Coll Physicians Surg Pak; 2007 Jun; 17(6):320-2. PubMed ID: 17623577
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.
Castelnau C; Le Gal F; Ripault MP; Gordien E; Martinot-Peignoux M; Boyer N; Pham BN; Maylin S; Bedossa P; Dény P; Marcellin P; Gault E
Hepatology; 2006 Sep; 44(3):728-35. PubMed ID: 16941695
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcome of HCV infected paediatric patients and young adults at Karachi, Pakistan.
Aziz S; Rajper J; Noorulain W
J Ayub Med Coll Abbottabad; 2012; 24(3-4):56-8. PubMed ID: 24669610
[TBL] [Abstract][Full Text] [Related]
8. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
Keskin O; Wedemeyer H; Tüzün A; Zachou K; Deda X; Dalekos GN; Heidrich B; Pehlivan S; Zeuzem S; Yalçın K; Gürel S; Tabak F; Idilman R; Bozkaya H; Manns M; Yurdaydin C
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2342-49.e1-2. PubMed ID: 26044319
[TBL] [Abstract][Full Text] [Related]
9. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.
Heidrich B; Yurdaydın C; Kabaçam G; Ratsch BA; Zachou K; Bremer B; Dalekos GN; Erhardt A; Tabak F; Yalcin K; Gürel S; Zeuzem S; Cornberg M; Bock CT; Manns MP; Wedemeyer H;
Hepatology; 2014 Jul; 60(1):87-97. PubMed ID: 24585488
[TBL] [Abstract][Full Text] [Related]
10. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.
Grabowski J; Yurdaydìn C; Zachou K; Buggisch P; Hofmann WP; Jaroszewicz J; Schlaphoff V; Manns MP; Cornberg M; Wedemeyer H;
Liver Int; 2011 Oct; 31(9):1395-405. PubMed ID: 21762356
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of the Peginterferon treatment in chronic hepatitis HDV and compensate liver cirrhosis.
Tugui L; Dumitru M; Iacob S; Gheorghe L; Preda C; Dinu I; Becheanu G; Dumbrava M; Nicolae I; Andrei A; Lupu A; Diculescu M
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):368-75. PubMed ID: 25076702
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response.
Samiullah S; Bikharam D; Nasreen
World J Gastroenterol; 2012 Oct; 18(40):5793-8. PubMed ID: 23155322
[TBL] [Abstract][Full Text] [Related]
15. Entecavir treatment of chronic hepatitis D.
Kabaçam G; Onder FO; Yakut M; Seven G; Karatayli SC; Karatayli E; Savas B; Idilman R; Bozdayi AM; Yurdaydin C
Clin Infect Dis; 2012 Sep; 55(5):645-50. PubMed ID: 22573857
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation of hepatitis D in Pakistani children.
Abbas Z; Soomro GB; Hassan SM; Luck NH
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1098-103. PubMed ID: 25089545
[TBL] [Abstract][Full Text] [Related]
17. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
Zachou K; Yurdaydin C; Drebber U; Dalekos GN; Erhardt A; Cakaloglu Y; Degertekin H; Gurel S; Zeuzem S; Bozkaya H; Schlaphoff V; Dienes HP; Bock TC; Manns MP; Wedemeyer H;
Liver Int; 2010 Mar; 30(3):430-7. PubMed ID: 19840253
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.
Erhardt A; Gerlich W; Starke C; Wend U; Donner A; Sagir A; Heintges T; Häussinger D
Liver Int; 2006 Sep; 26(7):805-10. PubMed ID: 16911462
[TBL] [Abstract][Full Text] [Related]
19. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
Heidrich B; Serrano BC; Idilman R; Kabaçam G; Bremer B; Raupach R; Önder FO; Deterding K; Zacher BJ; Taranta A; Bozkaya H; Zachou K; Tillmann HL; Bozdayi AM; Manns MP; Yurdaydın C; Wedemeyer H
Liver Int; 2012 Oct; 32(9):1415-25. PubMed ID: 22716112
[TBL] [Abstract][Full Text] [Related]
20. Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.
Mansour W; Ducancelle A; Le Gal F; Le Guillou-Guillemette H; Abgueguen P; Pivert A; Calès P; Gordien E; Lunel F
J Clin Virol; 2010 Jan; 47(1):97-9. PubMed ID: 19914127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
